Boscoe AN - Search Results

1

Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency.

Zagadailov E, Al-Samkari H, Boscoe AN, McGee B, Shi S, Macaulay D, Shi L, Garcia-Horton V. Zagadailov E, et al. Among authors: boscoe an. Hematology. 2024 Dec;29(1):2290746. doi: 10.1080/16078454.2023.2290746. Epub 2023 Dec 14. Hematology. 2024. PMID: 38095306

2

Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial.

Andrae DA, Grace RF, Jewett A, Foster B, Klaassen RJ, Salek S, Li J, Tai F, Boscoe AN, Zagadailov E. Andrae DA, et al. Among authors: boscoe an. J Patient Rep Outcomes. 2023 Nov 9;7(1):112. doi: 10.1186/s41687-023-00650-3. J Patient Rep Outcomes. 2023. PMID: 37943362 Free PMC article. Clinical Trial.

3

The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design.

Grace RF, van Beers EJ, Vives Corrons JL, Glader B, Glenthøj A, Kanno H, Kuo KHM, Lander C, Layton DM, Pospíŝilová D, Viprakasit V, Li J, Yan Y, Boscoe AN, Bowden C, Bianchi P. Grace RF, et al. Among authors: boscoe an. BMJ Open. 2023 Mar 23;13(3):e063605. doi: 10.1136/bmjopen-2022-063605. BMJ Open. 2023. PMID: 36958777 Free PMC article.

4

Burden of illness for patients with cholangiocarcinoma in the United States: a retrospective claims analysis.

Chamberlain CX, Faust E, Goldschmidt D, Webster N, Boscoe AN, Macaulay D, Peters ML. Chamberlain CX, et al. Among authors: boscoe an. J Gastrointest Oncol. 2021 Apr;12(2):658-668. doi: 10.21037/jgo-20-544. J Gastrointest Oncol. 2021. PMID: 34012657 Free PMC article.

5

Comorbidities and complications in adults with pyruvate kinase deficiency.

Boscoe AN, Yan Y, Hedgeman E, van Beers EJ, Al-Samkari H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Sharma M, Kuo KHM, Neufeld EJ, Wang H, Verhovsek M, Sheth S, Grace RF. Boscoe AN, et al. Eur J Haematol. 2021 Apr;106(4):484-492. doi: 10.1111/ejh.13572. Epub 2021 Jan 24. Eur J Haematol. 2021. PMID: 33370479 Free PMC article.

6

Prevalence of pyruvate kinase deficiency: A systematic literature review.

Secrest MH, Storm M, Carrington C, Casso D, Gilroy K, Pladson L, Boscoe AN. Secrest MH, et al. Among authors: boscoe an. Eur J Haematol. 2020 Aug;105(2):173-184. doi: 10.1111/ejh.13424. Epub 2020 Jun 23. Eur J Haematol. 2020. PMID: 32279356 Free PMC article.

7

Development of the pyruvate kinase deficiency diary and pyruvate kinase deficiency impact assessment: Disease-specific assessments.

Salek S, Boscoe AN, Piantedosi S, Egan S, Evans CJ, Wells T, Cohen J, Klaassen RJ, Grace R, Storm M. Salek S, et al. Among authors: boscoe an. Eur J Haematol. 2020 May;104(5):427-434. doi: 10.1111/ejh.13376. Epub 2020 Feb 24. Eur J Haematol. 2020. PMID: 31880847 Free PMC article.

8

Understanding side effects of therapy for myasthenia gravis and their impact on daily life.

Bacci ED, Coyne KS, Poon JL, Harris L, Boscoe AN. Bacci ED, et al. Among authors: boscoe an. BMC Neurol. 2019 Dec 21;19(1):335. doi: 10.1186/s12883-019-1573-2. BMC Neurol. 2019. PMID: 31864345 Free PMC article.

9

Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review.

Boscoe AN, Rolland C, Kelley RK. Boscoe AN, et al. J Gastrointest Oncol. 2019 Aug;10(4):751-765. doi: 10.21037/jgo.2019.03.10. J Gastrointest Oncol. 2019. PMID: 31392056 Free PMC article.

10

Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life.

Boscoe AN, Xin H, LʼItalien GJ, Harris LA, Cutter GR. Boscoe AN, et al. J Clin Neuromuscul Dis. 2019 Jun;20(4):173-181. doi: 10.1097/CND.0000000000000257. J Clin Neuromuscul Dis. 2019. PMID: 31135620 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page